Suppr超能文献

凝集素样氧化低密度脂蛋白受体-1:在动脉粥样硬化和心肌缺血中的意义。

LOX-1: Implications in atherosclerosis and myocardial ischemia.

作者信息

Sharma Tanya, Romeo Francesco, Mehta Jawahar L

机构信息

Division of Cardiology, Central Arkansas Veterans Healthcare System and the University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.

Department of Cardiology, International University Unicamillus, Rome, Italy.

出版信息

EXCLI J. 2022 Jan 13;21:273-278. doi: 10.17179/excli2021-4532. eCollection 2022.

Abstract

Understanding the pathophysiology of atherosclerosis is fundamental to the practice of cardiovascular medicine. Atherosclerosis is a multi-step cascade of accumulation of lipids and downstream changes that lead to a fibro-fatty plaque formation in the arterial intima. Multiple biochemical stimuli, cellular receptors and intra-cellular signals are implicated in this complex mechanism. Lectin-type oxidized LDL receptor-1 or LOX-1 is a type II membrane glycoprotein receptor which has emerged as an important effector of atherosclerosis. Hence, LOX-1 modification and its clinical consequences are of much interest in recent times.

摘要

了解动脉粥样硬化的病理生理学是心血管医学实践的基础。动脉粥样硬化是脂质积累及下游变化的多步骤级联反应,导致动脉内膜形成纤维脂肪斑块。多种生化刺激、细胞受体和细胞内信号参与了这一复杂机制。凝集素型氧化低密度脂蛋白受体-1(LOX-1)是一种II型膜糖蛋白受体,已成为动脉粥样硬化的重要效应因子。因此,近年来LOX-1修饰及其临床后果备受关注。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de76/8971323/789b86d0befe/EXCLI-21-273-t-001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验